Table 1.
Clinical characteristics of the patients (n = 29).
| Age at the Diagnosis | Hereditary Breast Cancer | ||
|---|---|---|---|
| Mean | 50.1 (± 8.72) | Yes | 3 (10.34%) |
| Range | 29–68 | No | 26 (89.66%) |
| Menopausal status | Tumor stage at diagnosis | ||
| Premenopausal | 10 (34%) | IIB | 5 (17.24%) |
| Postmenopausal | 16 (55%) | IIIA | 14 (48.28%) |
| Co-morbidities | IIIB | 7 (24.24%) | |
| Diabetes mellitus | 7 (24%) | IIIC | 3 (10.34%) |
| Systemic hypertension | 7 (24%) | Pathological complete response | |
| BMC * | PCR | 10 (34.48%) | |
| Mean | 27.94 (± 5.10) | Residual Disease | 19 (65.52%) |
| Previous pregnancy | Neoadjuvant chemotherapy with platinum salts | ||
| Yes | 24 (82.76%) | Yes | 10 (34.48%) |
| No | 5 (17.24%) | No | 19 (65.51%) |
| Oral contraceptives | DFS * (years) | ||
| Yes | 7 (24.24%) | Mean | 2 (± 2.24) |
| No | 22 (75.86%) | Range | 0–7.1 |
| OS * (years) | |||
| Mean | 5 (± 2.24) | ||
| Range | 0.7–11.1 | ||
* BMI = Body mass index, OS = Overall survival, DFS = Disease-free survival.